| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.06 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.06 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.06 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.06 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.074 | 0.06 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.099 | 0.06 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.07 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.14 | 0.07 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.07 |